linkedin

EYLEA (Non-English)

$1,499.00

Quantity Discount (%) Price
1 - 5 $1,499.00
6 - 10 6.67 % $1,399.00
11 - 20 7.34 % $1,389.00
21+ 8.01 % $1,379.00
, ,

EYLEA® (aflibercept) is a recombinant fusion protein formulated as an intravitreal injection to treat various retinal diseases caused by abnormal blood vessel growth and vascular leakage in the eye. It acts as a VEGF inhibitor, specifically binding to VEGF-AVEGF-B, and placental growth factor (PlGF), preventing these from interacting with their native receptors. This action helps reduce retinal edema, neovascularization, and vision loss. EYLEA® is commonly indicated for patients with neovascular (wet) age-related macular degeneration (wAMD)macular edema after retinal vein occlusion (RVO)diabetic macular edema (DME)diabetic retinopathy (DR), and retinopathy of prematurity (ROP). The product is administered under strict aseptic conditions by a trained ophthalmologist.

You were not leaving your cart just like that, right?

Enter your details below to save your shopping cart for later. And, who knows, maybe we will even send you a sweet discount code :)

Want to receive personalized offers?

Allow notifications to get real-time updates about your shopping cart and who knows, you may even receive a sweet discount code 😊

Maybe later
Medicadermal
Hello User

Join Our Newsletter

Subscribe to the CiyaShop mailing list to receive updates on new arrivals, special offers and other discount information.
Product added!
The product is already in the wishlist!
Removed from Wishlist